These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 3315608
21. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance data. Chamberlain DA. Drugs; 1987; 33 Suppl 3():286. PubMed ID: 3315609 [No Abstract] [Full Text] [Related]
22. Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction. Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW, Norry EC. Drugs; 1987; 33 Suppl 3():124-32. PubMed ID: 3315577 [Abstract] [Full Text] [Related]
23. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. Meinertz T, Kasper W, Schumacher M, Just H. Am J Cardiol; 1988 Sep 01; 62(7):347-51. PubMed ID: 3046283 [Abstract] [Full Text] [Related]
28. Systemic effects of anisoylated plasminogen streptokinase activator complex and streptokinase therapy in acute myocardial infarction. Coagulation aspects of the Dutch Invasive Reperfusion Study. Hoffmann JJ, Bonnier JJ, de Swart JB, Custers P, Vijgen M. Drugs; 1987 Sep 01; 33 Suppl 3():242-6. PubMed ID: 3315602 [Abstract] [Full Text] [Related]
29. Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW. Ann Intern Med; 1986 Mar 01; 104(3):304-10. PubMed ID: 3511819 [Abstract] [Full Text] [Related]
30. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction. Seabra-Gomes R, Aniceto Silva J, Aleixo A, Real T, Freire I, Torres I, Freitas R, Crespo F. Drugs; 1987 Mar 01; 33 Suppl 3():169-74. PubMed ID: 3315586 [Abstract] [Full Text] [Related]
31. Intracoronary streptokinase versus intravenous anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction. Kaspar L, Karnik R, Sehnal E, Zajicek P, Ziegler B, Slany J. Drugs; 1987 Mar 01; 33 Suppl 3():179-82. PubMed ID: 3315588 [Abstract] [Full Text] [Related]
32. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Hackworthy RA, Sorensen SG, Menlove RL, Anderson JL. Drugs; 1987 Mar 01; 33 Suppl 3():198-208. PubMed ID: 3315592 [Abstract] [Full Text] [Related]
33. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy. Crabbe SJ, Grimm AM, Hopkins LE. Pharmacotherapy; 1990 Mar 01; 10(2):115-26. PubMed ID: 2140889 [Abstract] [Full Text] [Related]
34. Intravenous fibrinolytic therapy of acute myocardial infarction: new perspectives from plasminogen activators? Kasper W, Meinertz T, Just H. Klin Wochenschr; 1986 Apr 01; 64(7):301-6. PubMed ID: 3086619 [Abstract] [Full Text] [Related]
35. Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. de Swart JB. Drugs; 1987 Apr 01; 33 Suppl 3():279-81. PubMed ID: 3315607 [No Abstract] [Full Text] [Related]
36. A randomised placebo-controlled pilot dose-response study with anisoylated plasminogen streptokinase activator complex in acute coronary artery occlusions. Leizorovicz A, Durrieu G, Boissel JP. Drugs; 1987 Apr 01; 33 Suppl 3():133-7. PubMed ID: 3315579 [Abstract] [Full Text] [Related]
37. Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Been M, de Bono DP, Muir AL, Boulton FE, Hillis WS, Hornung R. Br Heart J; 1985 Mar 01; 53(3):253-9. PubMed ID: 3882107 [Abstract] [Full Text] [Related]
38. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study. Renkin J, Beys CC, Lavenne-Pardonge E, Pintens H, Col J. Drugs; 1987 Mar 01; 33 Suppl 3():253-60. PubMed ID: 3315603 [Abstract] [Full Text] [Related]
39. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study. Timmis AD, Griffin B, Crick JC, Sowton E. J Am Coll Cardiol; 1987 Jul 01; 10(1):205-10. PubMed ID: 3298360 [Abstract] [Full Text] [Related]
40. Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study. Monnier P, Sigwart U, Vincent A, Bachmann F, Goy JJ, Schaller MD, Kaufmann U, Badan M, Grbic M, Perret C. Drugs; 1987 Jul 01; 33 Suppl 3():175-8. PubMed ID: 3315587 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]